Skip to main content
All lobbying filings

GLAUKOS CORPORATION

Lobbying for GLAUKOS CORPORATION · Research and product development

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · California · $45,000.00 expenses · posted Apr 16, 2025

Official filing document

 Bills named in this filing 5
  • HR 7024
    Tax Relief for American Families and Workers Act of 2024
  • HR 8702
    Improving Seniors’ Timely Access to Care Act of 2024
  • S 4532
    Improving Seniors’ Timely Access to Care Act of 2024
  • HR 972
    Outpatient Surgery Quality and Access Act of 2023
  • S 312
    Outpatient Surgery Quality and Access Act of 2023
 Lobbying activity 3
Taxation/Internal Revenue Code

Tax Relief for American Families and Workers Act of 2023 H.R. 7024

Medicare/Medicaid

H.R. 8702/S. 4532 Improving Seniors Timely Access to Care Act of 2024 H.R. 972/ S. 312 Outpatient Surgery Quality and Access Act of 2023

Medical/Disease Research/Clinical Labs

Legislation regarding FDA regulation of combination products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem